GO:0061047 positive regulation of branching involved in lung morphogenesis: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061047 describes any process that increases the rate, frequency, or extent of lung branching morphogenesis, the reiterated budding and subdivision that builds the respiratory tree.
• FGF10, SHH, BMP4, and VEGF-A are core regulators of branching, acting through epithelial-mesenchymal crosstalk.
• Disrupted branching underlies congenital lung malformations and bronchopulmonary dysplasia, with HOXB5 and Iroquois genes implicated in human and animal models.
• TNF-alpha converting enzyme (TACE/ADAM17) activity is required for embryonic lung branching in culture, linking proteolysis to morphogenesis.
• Integrin beta 1 suppresses epithelial multilayering, a process that can impair normal branching.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of branching regulators in lung epithelial cells and organoids.
Description
Branching morphogenesis is the developmental process that generates the complex tree-like architecture of the lung, consisting of reiterated rounds of bud outgrowth, elongation, and dichotomous subdivision of terminal units. The Gene Ontology term GO:0061047, positive regulation of branching involved in lung morphogenesis, captures any process that increases the rate, frequency, or extent of this branching program. This term is essential for researchers because precise control of branching is required for adequate gas-exchange surface area, and its dysregulation is linked to congenital lung malformations and neonatal respiratory diseases. Understanding the positive regulators of branching provides mechanistic insight into lung development and identifies candidate targets for regenerative medicine and disease modeling.
positive regulation of branching involved in lung morphogenesis At A Glance
| GO ID | GO:0061047 |
|---|---|
| GO term | positive regulation of branching involved in lung morphogenesis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Enhances the rate, frequency, or extent of lung branching morphogenesis |
| Key regulators | FGF10, SHH, BMP4, VEGF-A, TACE/ADAM17, HOXB5, Iroquois genes, Integrin beta 1 |
| Related processes | Epithelial-mesenchymal crosstalk, bud outgrowth, dichotomous subdivision |
| Disease relevance | Congenital lung malformations, bronchopulmonary dysplasia, lung hypoplasia |
What Is GO:0061047?
GO:0061047 is a biological process term defined as any process that increases the rate, frequency, or extent of the process in which a highly ordered sequence of patterning events generates the branched structures of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units. In simpler terms, it covers the molecular and cellular events that promote or enhance the formation of new branches in the developing lung.
Why Is positive regulation of branching involved in lung morphogenesis Important in Cell Biology?
Positive regulation of branching morphogenesis is critical because the lung's gas-exchange capacity depends on the total number of branches and alveoli generated during development. Disruptions in this process cause congenital lung malformations, pulmonary hypoplasia, and bronchopulmonary dysplasia, and understanding the positive regulators can inform strategies for lung regeneration and tissue engineering.
• Determines final lung size and respiratory surface area.
• Required for proper epithelial-mesenchymal crosstalk during development.
• Dysregulation leads to congenital lung malformations such as cystic adenomatoid malformation.
• Implicated in bronchopulmonary dysplasia and prematurity-related lung disease.
• Provides targets for regenerative medicine and lung tissue engineering.
• Serves as a paradigm for branching in other organs like kidney and mammary gland.
• Links proteolytic signaling (TACE/ADAM17) to morphogenetic events.
• Involves integrin-mediated adhesion that controls epithelial architecture.
What Happens During positive regulation of branching involved in lung morphogenesis?
Initiation of bud outgrowth
In simple terms: The lung starts as a small tube that sprouts new buds.
Branching begins when localized FGF10 signaling from the mesenchyme induces epithelial bud formation. FGF10 acts as a chemoattractant and mitogen for lung epithelial cells, and its expression is regulated by SHH and BMP4 feedback. Positive regulation of this step increases the number of initial buds.
Elongation and dichotomous subdivision
In simple terms: The buds grow longer and then split into two new branches.
After bud formation, the epithelial tube elongates and undergoes dichotomous subdivision, a process requiring coordinated cell proliferation, migration, and extracellular matrix remodeling. VEGF-A signaling through Flk-1 facilitates epithelial-endothelial crosstalk that supports branching. TACE/ADAM17 activity is also necessary for embryonic lung branching in culture, likely through shedding of growth factors.
Epithelial-mesenchymal crosstalk
In simple terms: Cells from different layers talk to each other to coordinate branching.
Branching morphogenesis relies on reciprocal signaling between the epithelium and mesenchyme. FGF10 from mesenchyme signals to FGFR2b on epithelium, while epithelial SHH signals back to mesenchyme to restrict FGF10 expression. Positive regulators enhance these signaling loops to promote branching.
Role of proteolysis and adhesion
In simple terms: Enzymes that cut proteins and adhesion molecules help shape branches.
TACE/ADAM17-mediated shedding of membrane-bound growth factors is required for branching, as abrogation of TACE inhibits embryonic lung morphogenesis in culture. Integrin beta 1 suppresses multilayering of the simple epithelium, and loss of integrin beta 1 leads to abnormal epithelial architecture that can impair branching.
Key Genes Involved in GO:0061047 positive regulation of branching involved in lung morphogenesis
The following genes and proteins are key positive regulators or modulators of lung branching morphogenesis, based on experimental evidence from animal models and human studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FGF10 | Mesenchymal signal that induces epithelial bud outgrowth | Knockout causes lung agenesis; key target for branching studies |
| FGFR2b | Epithelial receptor for FGF10 | Mediates FGF10 signaling; mutations affect branching |
| SHH | Epithelial signal that restricts FGF10 to distal mesenchyme | Knockout leads to increased FGF10 and abnormal branching |
| BMP4 | Regulates FGF10 expression and epithelial differentiation | Involved in branching inhibition and proximal-distal patterning |
| VEGF-A | Promotes epithelial-endothelial crosstalk | Required for early lung branching; Flk-1 receptor mediates effects |
| Flk-1 (KDR) | VEGF receptor | Facilitates endothelial signaling during branching |
| TACE/ADAM17 | Protease that sheds growth factors | Inhibition blocks embryonic lung branching in culture |
| HOXB5 | Transcription factor involved in lung development | Expressed during human lung development; linked to congenital malformations |
| Iroquois genes (IRX1-6) | Transcription factors influencing proximo-distal patterning | Influence branching and differentiation in rat lung |
| Integrin beta 1 | Cell adhesion receptor | Suppresses epithelial multilayering; loss impairs branching |
| Activin A | TGF-beta family ligand | Regulates branching morphogenesis in lung |
| TGF-beta | Signaling molecule | Modulates branching through SMAD pathways |
| Wnt7b | Secreted signaling molecule | Promotes epithelial differentiation and branching |
| Sox9 | Transcription factor | Marks distal epithelial progenitors during branching |
| Id2 | Inhibitor of DNA binding | Regulates proximal-distal patterning |
| Nkx2.1 | Transcription factor | Essential for lung specification and branching |
| GATA6 | Transcription factor | Regulates epithelial differentiation and branching |
| Foxa2 | Transcription factor | Involved in lung epithelial development |
How Is positive regulation of branching involved in lung morphogenesis Regulated?
Positive regulation of lung branching is controlled by a network of signaling pathways, including FGF, SHH, BMP, VEGF, and TGF-beta. FGF10 signaling is positively regulated by Wnt/beta-catenin and negatively by SHH and BMP4, creating a feedback loop that determines branch sites. VEGF-A signaling through Flk-1 promotes epithelial-endothelial crosstalk and branching. Proteolytic activity of TACE/ADAM17 is required for shedding of growth factors that enhance branching. Integrin beta 1 signaling maintains epithelial monolayer integrity, and its loss leads to multilayering that can disrupt branching.
positive regulation of branching involved in lung morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FGF10 | Lung agenesis, branching defects | Knockout mouse, lung organoid |
| HOXB5 | Congenital lung malformations | Knock-in/knockout human cell lines |
| VEGF-A | Bronchopulmonary dysplasia | Overexpression in lung epithelial cells |
| Iroquois genes | Impaired proximo-distal patterning | Knockdown in rat lung explants |
| Integrin beta 1 | Epithelial multilayering, branching defects | Conditional knockout mouse |
Congenital lung malformations
Disrupted branching morphogenesis is associated with congenital lung malformations such as congenital cystic adenomatoid malformation (CCAM). HOXB5 expression is altered in human congenital lung malformations, suggesting a role in disease pathogenesis. Animal models with mutations in FGF10, SHH, or BMP4 exhibit severe lung branching defects.
Bronchopulmonary dysplasia (BPD)
BPD is a chronic lung disease of preterm infants characterized by impaired alveolarization and branching. Iroquois gene expression is altered in rat models of impaired lung development, and these genes influence proximo-distal morphogenesis. VEGF-A signaling defects are also implicated in BPD-like phenotypes.
Lung hypoplasia
Insufficient positive regulation of branching can lead to lung hypoplasia, a condition with reduced lung volume. FGF10 knockout mice exhibit lung agenesis, demonstrating the critical role of this pathway. TACE inhibition in culture blocks branching, highlighting the importance of proteolytic regulation.
From positive regulation of branching involved in lung morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote branching? | Knockout in lung epithelial cells or organoids |
| Does a point mutation in gene X affect branching? | Point-mutation knock-in via CRISPR |
| Does overexpression of gene X enhance branching? | Overexpression cell line or transgenic mouse |
| Where is gene X expressed during branching? | Tagged knock-in with fluorescent reporter |
| What is the effect of gene X on epithelial architecture? | 3D organoid culture with CRISPR KO |
| Does gene X interact with FGF10 signaling? | Co-culture and biochemical assays |
How to Study the positive regulation of branching involved in lung morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lung explant culture | Branching rate and pattern | Testing inhibitors/activators |
| Organoid assay | Bud formation and self-organization | Gene knockout studies |
| RNA-seq | Transcriptional changes | Identifying branching regulators |
| Spatial transcriptomics | Gene expression in tissue context | Mapping FGF10/SHH gradients |
| Proteomics | Protein abundance and modifications | Signaling pathway analysis |
| Immunofluorescence | Protein localization | Validating expression patterns |
| Time-lapse imaging | Dynamic branching events | Quantifying branch initiation |
Lung explant culture and branching assays
Embryonic lung explants cultured ex vivo allow direct observation of branching. Treatment with inhibitors or growth factors, such as TACE inhibitors, can reveal positive regulators. Time-lapse imaging quantifies branch number and length.
Organoid models
Lung organoids derived from epithelial progenitors recapitulate branching morphogenesis in vitro. CRISPR knockout of candidate genes in organoids can test their role in bud formation and subdivision.
RNA-seq and spatial transcriptomics
Transcriptomic profiling of microdissected branching tips versus stalks identifies genes enriched in active branching regions. Spatial transcriptomics can map expression of FGF10, SHH, and BMP4 during branching.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can identify signaling changes downstream of FGF10 or VEGF-A. Phosphoproteomics reveals kinase activities that positively regulate branching.
How CRISPR Can Be Used to Study GO:0061047 positive regulation of branching involved in lung morphogenesis
Knockout
CRISPR knockout of candidate positive regulators (e.g., FGF10, VEGF-A) in lung epithelial cells or organoids can determine whether they are required for branching. Loss-of-function phenotypes are assessed by reduced bud number or impaired subdivision.
Point Mutation
Point mutations in genes like FGFR2b or HOXB5 can be introduced to model human variants associated with congenital lung malformations. These knock-in models test the functional impact of specific alleles on branching.
Knock-in
Knock-in of fluorescent reporters (e.g., GFP) into endogenous loci such as SHH or FGF10 allows live imaging of branching dynamics. Tagged knock-in also enables chromatin immunoprecipitation or proteomic studies.
Overexpression
Overexpression of positive regulators like VEGF-A or FGF10 in lung epithelial cells can enhance branching in culture. This approach tests sufficiency and identifies downstream effectors.
How EDITGENE Supports positive regulation of branching involved in lung morphogenesis Research
Researchers studying positive regulation of branching involved in lung morphogenesis-related genes often need to determine whether a candidate gene is causally involved in branching or simply correlated with it. CRISPR-based models provide the gold standard for establishing causality, and EDITGENE offers a comprehensive suite of services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of branching involved in lung morphogenesis research.
Frequently Asked Questions About positive regulation of branching involved in lung morphogenesis
What is GO:0061047?
GO:0061047 is the Gene Ontology term for positive regulation of branching involved in lung morphogenesis, describing any process that increases the rate, frequency, or extent of lung branching.
What genes are involved in positive regulation of lung branching?
Key genes include FGF10, SHH, BMP4, VEGF-A, TACE/ADAM17, HOXB5, Iroquois genes, and Integrin beta 1.
How does FGF10 regulate lung branching?
FGF10 from the mesenchyme signals to FGFR2b on epithelial cells to induce bud outgrowth and is essential for branching.
What diseases are associated with abnormal lung branching?
Congenital lung malformations, bronchopulmonary dysplasia, and lung hypoplasia are linked to disrupted branching.
What methods are used to study lung branching morphogenesis?
Lung explant culture, organoid assays, RNA-seq, spatial transcriptomics, and CRISPR screens are commonly used.
How can CRISPR be used to study branching morphogenesis?
CRISPR knockout, knock-in, point mutation, and overexpression models allow causal testing of candidate genes in lung cells and organoids.
What is the role of VEGF-A in lung branching?
VEGF-A signaling through Flk-1 facilitates epithelial-endothelial crosstalk and is critical for early embryonic lung branching.
What is the role of TACE in lung branching?
TACE/ADAM17 protease activity is required for embryonic lung branching in culture, likely through shedding of growth factors.
How do I choose a model for branching morphogenesis research?
Consider knockout for loss-of-function, knock-in for tagging or mutations, and overexpression for sufficiency studies; organoids and explants are ideal for branching assays.
What services does EDITGENE provide for lung branching research?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to lung morphogenesis studies.
Conclusion
GO:0061047 positive regulation of branching involved in lung morphogenesis is a fundamental developmental process that governs the formation of the respiratory tree. Key signaling pathways involving FGF10, VEGF-A, SHH, and BMP4, along with proteolytic and adhesion molecules, orchestrate this process. Disruptions lead to congenital lung malformations and neonatal lung diseases. CRISPR-based models and advanced omics technologies are essential for dissecting these mechanisms and identifying therapeutic targets.
References
- 1. Ball EM et al.. 2001. Activins as regulators of branching morphogenesis.. Dev Biol 238(1):1-12 PMID: 11783989
- 2. Bellusci S et al.. 1997. Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung.. Development 124(23):4867-78 PMID: 9428423
- 3. Zhao J et al.. 2001. Abrogation of tumor necrosis factor-alpha converting enzyme inhibits embryonic lung morphogenesis in culture.. Int J Dev Biol 45(4):623-31 PMID: 11460998
- 4. Nigam SK et al.. 2009. How does the ureteric bud branch?. J Am Soc Nephrol 20(7):1465-9 PMID: 19056872
- 5. Volpe MV et al.. 2003. Expression of Hoxb-5 during human lung development and in congenital lung malformations.. Birth Defects Res A Clin Mol Teratol 67(8):550-6 PMID: 14632303
- 6. Del Moral PM et al.. 2006. VEGF-A signaling through Flk-1 is a critical facilitator of early embryonic lung epithelial to endothelial crosstalk and branching morphogenesis.. Dev Biol 290(1):177-88 PMID: 16375885
- 7. van Tuyl M et al.. 2006. Iroquois genes influence proximo-distal morphogenesis during rat lung development.. Am J Physiol Lung Cell Mol Physiol 290(4):L777-L789 PMID: 16299054
- 8. Chen J et al.. 2012. Integrin Beta 1 suppresses multilayering of a simple epithelium.. PLoS One 7(12):e52886 PMID: 23285215
